News

Flemish Government awards extra budget for VIB’s ambitious plans for the future
20 February 2017
The Flemish Minister for Work, Economy, Innovation and Sport, Philippe Muyters, together with VIB's managing directors Jo Bury&Johan Cardoen and chairman of VIB’s board of directors, Ajit Shetty, signed agreement between the Flemish Government and VIB
VIB Matinee in the Flemish Parliament: Flemish Government invests heavily in VIB
20 February 2017
The new strategic plan of VIB was signed at the Flemish Parliament. VIB took the opportunity to introduce itself and present its achievements and its future plans to parliamentarians, policy officers,..
VIB Tech Transfer takes research to private partners and beyond
18 February 2017
As important as fundamental research is to new insights and discoveries, VIB is also committed to transforming those insights into real products, crops, medicines and therapies that improve lives.
How our Switch lab plans to catch tumors in a spider’s web
17 February 2017
Proteins all share a similar structural element: amyloid. Although these ‘clumps’ of proteins are usually associated with disease development, their properties could be used to fight a wide array of conditions.
Children of patients with C9orf72 mutations are at a greater risk of frontotemporal dementia or ALS at a younger age
14 February 2017
Researchers from VIB and UAntwerp, headed by Prof. Christine Van Broeckhoven, have demonstrated that if an affected parent passes on this mutation, the children will be affected at a younger age (than the parent).
Researchers identify phosphorylation process vital to cancer growth
14 February 2017
Scientists at VIB-KU Leuven have identified a new mechanism that impacts tumor growth. The typical lack of oxygen in tumors doesn’t only stimulate proliferation, but also offsets the important role of the protein PHD2 as ‘cancer cell killer’.
Scientists isolate new antibodies to fight human respiratory syncytial virus (RSV)
13 February 2017
Researchers from VIB, UGent, the Geisel School of Medicine at Dartmouth and several collaborators developed a new antiviral strategy to fight human respiratory syncytial virus (RSV), a leading cause of lower respiratory tract infections in children.
Diverse VIB team investigates the possibilities of plant proteins
11 February 2017
Although both plants and animals are made up of cells, plants are generally unable to relocate, and thus can’t migrate around freely like animals can.
Mitochondrial lipids as potential targets in early onset Parkinson’s disease
10 February 2017
A team of researchers led by Patrik Verstreken (VIB–KU Leuven) identified an underlying mechanism in Parkinson’s disease. Using flies, mice and patient cells, the team focused on cardiolipin organelles that produce energy
Launch ELIXIR Belgium - Tackling data management together
9 February 2017
Life-sciences go through a number of data challenges that force the scientific community to rethink many aspects of data management. To encounter these challenges and to share data amongst European researchers, the ELIXIR initiative was launched.
Surprise finding leads to new insights into splenic B cell differentiation
2 February 2017
Bart Lambrecht & team demonstrated that mice genetically lacking in Taok3 did not develop MZB cells & are more susceptible to bacterial infection. Insights lead to potential new molecular therapies for genetic conditions, asthma and diabetes.
New Horizon 2020 Project B-SMART Develops RNA-based Therapy for Neurodegenerative Diseases
1 February 2017
Neurodegenerative diseases such as Alzheimer’s affect over 7 million people in Europe – a figure which is expected to double every 20 years as the population ages and thus poses a significant healthcare burden to European society.
Physical barrier in microscopy overcome by VIB scientists
30 January 2017
Scientists at VIB have taken the potential of confocal microscopy across the diffraction barrier – using innovative software-based image analysis tools.
Ghent-based researchers are the cream of the crop in rheumatology
28 January 2017
As an umbrella term, rheumatism covers dozens of specific diseases of the muscles, joints and bones – which require different treatments. Because an overall cure remains undiscovered, patients and their associations are placing their hopes in science.
Science Meets Society - Communicating complex issues
26 January 2017
VIB and Ghent University organize the first edition of the Science Meets Society seminar on the 18th of March in Ghent.

«Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS